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In order to determine dermoscopic parameters, a case-
control test set of naevus-associated melanomas vs de 
novo melanomas paired by Breslow thickness and his-
topathological subtype was analysed by 2 blinded expe-
rienced dermoscopists, according to presence of naevus, 
pattern analysis and ABCD dermoscopy score. The abi-
lity to identify naevus-associated melanomas by pattern 
analysis was low for both blinded dermoscopists (κ < 0.2). 
Dermoscopy features associated with naevus-associated 
melanomas were: presence of negative pigment network 
(OR 9.915, CI 95% 2.182–45.049), globules (OR 2.383, 
CI 95% 1.15–4.95) and streaks (OR 2.439, CI 95% 1.271–
4.680). In contrast, the presence of blue-white veil was 
related to absence of associated naevus (OR 0.520, CI 
95% 0.273–0.991). With the results obtained, 2 different 
algorithms were proposed. The use of the proposed algo-
rithms could help raise awareness of naevus-associated 
melanomas and avoid the possibility of incorrectly diag-
nosing a naevus-associated melanoma if partial biopsies 
are performed. Key words: naevus-associated melanoma; 
de novo melanoma; dermoscopy; biopsy.
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Association of melanoma with a pre-existing naevus is 
still a debated subject in the literature. Melanoma seems 
to arise either in association with a pre-existing naevus 
or de novo, without any associated lesion. 
At the histopathological level, benign naevus cells 
are found in association with 20–50% of melanomas 
(1–10). Factors, such as tumour thickness, could be 
responsible for a confounding role in such discrepant 
values, since naevus are more easily demonstrated in 
thinner tumours and may have been destroyed in thicker 
ones (5, 11). 
In the diagnosis of melanocytic lesions, the role of 
partial biopsies has been long discussed, but there is 
still no consensus among practitioners of whether or 
not to perform a whole lesion excision for diagnosis 
(12, 13). But considering the fact that as many as 50% 
of tumours may be in contiguity of benign naevus rem-
nants (2), the role of partial biopsies for diagnosis of 
melanocytic lesions could be herein condemned, since 
the pathologist may only encounter benign naevus cells 
and be confounded in the diagnosis of melanoma. This 
is also one of the main reasons why step-sectioning 
should be the standard in the pathology procedure for 
the diagnosis of melanocytic lesions to avoid not cor-
rectly diagnosing a melanoma. 
Dermoscopy is a non-invasive technique that in-
creases the diagnostic accuracy in the diagnosis of 
melanoma (14, 15). It has been previously assessed as a 
tool in the recognition of naevus-associated melanoma 
(NA-M) in a study of 108 consecutive diagnosed thin 
melanomas that were evaluated for dermoscopic criteria 
(16). Stante et al. (16) found that NA-M show atypical 
pigment network and regression when compared to de 
novo melanomas (DN-M). Since it has been previously 
referred in the literature that NA-M are more frequent 
on the trunk and  DN-M are more frequent on head and 
neck (8), and that Stante et al. evaluated a consecutive 
melanoma sample, not taking into account thickness, 
location or subtype of the melanomas, the findings of 
this previous study could be primarily related to the 
location of the melanomas rather than specific criteria 
for NA-M. In order to avoid this bias, we proposed a 
case control study of NA-M and  DN-M, controlling for 
thickness and melanoma subtype in order to evaluate 
the dermoscopy of NA-M. 
METHODS
This study was approved by the Ethics committee of the Hos-
pital Clinic, Barcelona Spain. 
All lesions were excised during the same time period 
(2008–2013) at the Melanoma Unit of Hospital Clinic, Barce-
lona. Pathological records evaluated by a highly experienced 
pathologist (Alos), with a diagnosis of melanoma and NA-M 
were included in this study. Benign naevomelanocytic aggre-
gates (i.e. typical junctional, compound or dermal naevomela-
nocytic nevus, junctional or compound dysplastic naevi) were 
considered as “naevi” in this study (17–19). Only lesions with 
dermoscopic images were selected for the case control test set. 
Selected melanomas were further paired according to Breslow 
thickness, histopathological subtype and location (when poss-
ible) based on data available in the pathological records. The 
final test set consisted of 81 NA-M and 80 DN-M.
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Fig. 2. Area under the curve: showing that the best diagnostic technique for naevus associated melanoma 
is Algorithm I.
Dermoscopy images were obtained with a Dermlite Foto 
(3GEN), and a Canon camera ( Canon Powershot G7, 10 mega 
pixels) and retrospectively evaluated.
The dermoscopic images were randomised to compose a test 
set. Two blinded dermatologists, highly experienced in der-
moscopy (minimum 7-year training) were each independently 
asked to evaluate images on a computer screen. First, each one 
was asked to try to determine whether the dermoscopic image 
corresponded to a NA-M or a DN-M analysing the overall pat-
tern of the lesion. If the evaluator considered the lesion to be a 
NA-M, they were asked to draw the area of the lesion, which 
they considered corresponded to the naevus (Island sign) (20).
 The evaluators were further asked to evaluate the melano-
mas according to dermoscopic pattern analysis parameters: 
type of global pattern present (reticular, globular, cobblestone, 
starburst, homogeneous, multicomponent, unspecific), and the 
presence or absence of local dermoscopy features (atypical 
network, dots and globules, streaks (streaks and/or pseudopods) 
(21), blue white veil, regression (i.e., scar like depigmenta-
tion and/or peppering), hypopigmentation, blotch, vascular 
structures (milky red globules, comma vessels, dotted vessels, 
polymorphic vessels). The presence or absence of new para-
meters such as negative pigment network (22) and shiny white 
streaks were also evaluated, since 
polarised images for all lesions 
were available (23). 
Further, the parameters for the 
ABCD Rule for dermo scopy were 
assessed as follows: presence of 
asymmetry on 1 or 2 axes (× 1.3), 
number of sharply ending borders 
(× 0.1), number of colours present 
(white, red, brown, blue-gray and 
black) (× 0.5) and presence of dif-
ferent structures (network, dots, 
globules, streaks and structureless 
areas) (× 0.5) and a Total Dermos-
copic Score (TDS) was calculated, 
as described previously (24). Le-
sions on the face and acral sites 
were excluded from the evaluation 
of TDS score due to peculiarities 
in the dermoscopic diagnosis of 
melanomas at these sites, as des-
cribed elsewhere (24). However, 
melanomas on the face were 
evaluated according to previously 
described dermoscopic criteria for 
facial areas: presence or absence 
of asymmetrically pigmented 
follicular openings, rhomboidal 
structures, annular-granular pattern, homogeneous areas, 
fingerprint-like areas, pseudo-cysts, moth-eaten border (25, 26).
Statistical analysis
Statistical assay was performed using the SPSS version 16 pro-
gram. Pearson χ2 and symmetric measures of risk were calculated 
with a significant p < 0.05 and a confidence interval of 95%. 
An algorithm for predicting NA-M was developed as follows: 
each dermoscopic criterion statistically positively associated 
with NA-M was awarded a value of +1 and each criterion 
statistically negatively associated with NA-M was awarded a 
value of (–1) (Algorithm I). 
A second algorithm created included only those dermoscopic 
criteria statistically positively associated with NA-M, with 
each criterion present receiving a value of +1 (Algorithm II). 
Sensitivity and specificity were calculated for each observer, 
algorithm I, algorithm II, and each dermoscopic criterion sta-
tistically associated with NA-M. The best cut off point of the 
score was selected according to the accuracy of the algorithm.
Fig. 1. Dermoscopic images of 4 melanomas arising in a naevus. Negative pigment network (+1) and globules (+1) with a Score for Algorithm I of +2 
and the same for Algorithm II (a). Globules (+1) (b) and Streaks (+1) (c) with a Score for Algorithm I of +1 and the same for Algorithm II. Streaks (+1) 
and globules (+1) with a Score for Algorithm I of +2 and the same for Algorithm II (d). All lesions were true positives (melanomas arising in a naevus) 
for Algorithm I and Algorithm II.
1http://www.medicaljournals.se/acta/content/?doi=10.2340/00015555-2009
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Receiver Operating Characteristic (ROC) curve and area under 
the curve were calculated for each criterion associated with mela-
noma arising in a naevus, for each algorithm and for the TDS score. 
RESULTS
The melanoma test set consisted of 161 tumours, 81 
being NA-Ms and 80 DN-Ms, 49 being in situ (30.4%) 
and 112 invasive (69.6%). 
In regard to histopathological subtype, 120 were super-
ficial spreading melanoma (74.5%), 8 acral lentiginous 
melanoma (4.9%), 5 nodular melanoma (3.1%), 3 lentigo 
malignant melanoma (1.9%) and 25 in situ melanomas 
without any histopathological sub-classification (15.5%). 
Regarding the lesion site, 10 melanomas were located 
on the head, 75 affected the trunk, 58 the limbs and 9 
were on acral sites. In 9 cases the primary location was 
not available. Unfortunately, in order to keep paired 
Breslow thickness between both groups, site distribution 
between trunk (59% NA-M and 41% DN-M) and limbs 
(30% NA-M and 70% DN-M) could not be completely 
equivalent (p < 0.05). The distribution of acral or facial 
melanomas was similar between groups (NA-M and 
DN-M) and there was no difference in Breslow thickness 
(1.38 for NA-M and 1.20 for DN-M; p = 0.763).
When considering the dermoscopic parameters 
evaluated, the presence of globules (p < 0.018), the 
presence of streaks (p < 0.007) and the presence of ne-
gative pigment network (p < 0.000) were significantly 
related to a NA-M (Fig 1, Table SI1), the latter being 
the most specific criterion. In contrast, the presence of 
blue-white veil (p = 0.046) was related to absence of 
associated naevus (Fig. S11). No significant difference 
was found among the other dermoscopic criteria nor 
any global pattern in pattern analysis.
The sensitivity and specificity of diagnosing a NA-M 
is presented in Table I. Considering solely dermoscopy 
pattern analysis evaluation, the sensitivity for both 
blind evaluators was below 50% and the kappa value 
with histopathology of both blinded dermatologists 
was lower than 0.2. The sensitivity and specificity of 
each dermoscopic parameter significantly related to 
NA-M were evaluated as well. The mean TDS score 
for NA-Ms and DN-Ms was very similar (5.98 and 6.00 
respectively; p = 0.95). 
Two algorithms were developed: the first awarded a 
value of +1 to criterion, highly associated with NA-M 
(globules, streaks and negative pigment network), and 
a value of –1 for the presence of blue white veil, which 
is inversely associated with melanoma arising in a nae-
vus. A second algorithm was developed including only 
positive criteria with a value of +1 for each criterion 
(globules, streaks and negative pigment network). 
The score being greater than 1 conveyed a sensitivity 
in the diagnosis of NA-M of 80.3% and a specificity of 
54.5% for the first algorithm. In the second algorithm, 
which excluded the Blue White Veil parameter, there 
was an increase in sensitivity in detriment of specificity. 
But when considering the ROC curve area, for compare 
the performance of the proposed algorithms, TDS score 
and each parameter statistically associated with NA-M, 
the greatest contemplated area corresponded to the first 
algorithm (G+P+NN-V) (Fig. 2).
DISCUSSION
Only one previous study specifically analysed the der-
moscopy criteria associated with melanoma arising in a 
naevus. They showed that atypical pigment network and 
regression structures were associated with melanomas 
arising in a naevus (16). That study was not controlled 
by the pathological subtype of primary melanoma nor 
Breslow thickness, both being possible biases for der-
moscopy evaluation. When using a study set of NA-Ms 
and DN-Ms controlled by Breslow thickness, histopat-
hological type and by site (at least for acral and facial), 
no atypical pigment network nor regression structures to 
be associated with the presence of an NA-M were found.
This discrepancy could be explained by the type of 
sample of the previous study. Stante et al. (16) eva-
luated 108 consecutive melanomas, 35 were NA-M 
and 73 DN-M. The majority of NA-M were invasive 
melanomas, while most of the DN-Ms were in situ. In 
the present study, in situ melanomas were well balan-
ced between both groups. It has been previously sug-
gested that regression structures may vary depending 
on whether the melanoma is in situ or invasive (27, 
28). Also, in the study by Stante et al., 66% of NA-M 
were located on the trunk, whilst 58% of DN-Ms were 
located elsewhere, including the face. In the present 
study, at least for acral and facial sites, the distribution 
was well balanced, and for trunk and extremities it was 
less divergent. Since dermoscopic criteria may vary ac-
cording to lesion site, this different distribution could 
also justify the absence of similar findings in our study. 
Table I. Sensitivity and Specificity of distinct parameters regarding the diagnosis of naevus-associated melanoma









Sens 48.4% 35.9% 80.3% 94.4% 78.9% 55.4% 20.3% 63.5%
Specif 49.2% 77.5% 54.5% 28.6% 39% 66.2% 97.5% 52.5%
Algorithm I: +1 (for each parameter present: globules, streaks and negative pigment network) –1 (if presence of blue white veil).
Algorithm II: +1 (for each parameter present: globules, streaks and negative pigment network).
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Even though recent findings that benign dermoscopic 
features, such as cobblestone pattern, homogeneous 
pattern, typical pigment network, are more frequently 
associated with NA-M than DN-M (11), none of these 
parameters showed any difference between NA-M and 
DN-M in the present study. The difference in these 
results may relate to the sample of each study, since 
Di Stefani considered 373 consecutive melanomas 
for analysis, neither paired for Breslow thickness, nor 
histopathological subtype. 
Nevertheless, we found the presence of globules and 
streaks to be related with NA-M. This seems compatible 
with the fact that globules are dermoscopic parameters 
related to melanocytic cells aggregated in nests and a 
common dermoscopic parameter for naevi (15). Also, 
streaks, according to histopathology and confocal 
microscopy correlation studies, seem to correspond 
to globular-like structures at the extremity, but with a 
comet star-like appearance (29, 30). 
The negative pigment network (NPN) is conside-
red to be a melanoma feature, being more frequent 
than previously described (31). Even though it was 
recently suggested that NPN and Shiny White Streaks 
(SWS, also known as Chrysalis structures) could be 
manifestations of the same histopathological finding 
(changes in orientation and composition of collagen in 
stroma), NPN and SWS refer to different dermoscopic 
parameters (32). NPN is described as relatively light 
areas making up the “cords” of the network, and darker 
areas filling the holes, making it appear as a negative 
of the pigmented network (22, 33); while SWS is des-
cribed as shiny, bright, often orthogonal, unconnected 
white lines that do not make up a network pattern (34). 
It has previously been suggested that the presence of 
NPN is associated with in situ melanoma arising on a 
naevus, in 66.7% of the cases and it could represent 
the expression of fibrotic regression, as a reaction of 
a benign lesion against the malignant evolution (35). 
Indeed our findings support this since NPN is present 
in 88.0% of the NA-Ms, and represents a 9.915 greater 
risk of being a NA-M [CI 95% (2.182–45.049)]. It is 
also of note that even though negative pigment network 
is not a typical naevus criterion, it was the single most 
specific criterion for melanoma associated with a naevus 
(97.5%). followed by streaks (66.2%), whilst presence 
of globules was the most sensitive parameter (78.9%). 
Recently, the appearance of a negative pigment network 
in a pre-existing melanocytic naevus in patients under 
treatment with BRAF inhibitors has been associated 
with the diagnosis of early melanomas arising in a nevus 
during the treatment (36), in agreement with our finding. 
The diagnosis of NA-M with dermoscopy yields dif-
ferent sensitivities and specificities (see Table I). It is 
difficult to diagnose a NA-M with the naked eye or even 
with broadly acknowledged dermoscopic methods, such 
as pattern analysis or the ABCD rule. Also, the inter-
observer reproducibility of the island sign (area supposed 
to correspond to the melanoma arising in a naevus) is 
low. Therefore, in an attempt to improve diagnosis of 
NA-M based on dermoscopy, we developed 2 different 
algorithms as described previously, with algorithm I 
having the best performance according to area under 
ROC curve. Even though the specificity of both propo-
sed algorithms was low, both improve the dermoscopic 
diagnosis of NA-M, so that fewer NA-M are incorrectly 
diagnosed by the use of partial biopsies, when facing a 
melanocytic lesion with benign appearance. 
This is to our knowledge the first study evaluating 
the dermoscopic parameters of NA-M controlled for 
parameters such as Breslow thickness, histopathological 
subtype and lesion site (in most cases), which could 
render bias in the results. 
The results of this study show that it is difficult to 
distinguish NA-M and DN-M based on dermoscopy, so 
when facing a melanocytic lesion with a benign appea-
rance or a benign pathological diagnosis, the presence 
of significantly associated features of NA-M, such as 
negative pigment network, globules and streaks, should 
raise the awareness of the dermatologist regarding the 
risk of not correctly diagnosing a NA-M. So if these 
dermoscopic criteria are present in a lesion and a naevus 
is not mentioned in the pathology report, the pathologist 
should then take a second look. Even though it is not 
directly analysed in our study, our results provide further 
evidenceof the need to avoid partial biopsies and to per-
form step sections for pathology. 
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